Here is the latest from the Macular Societies January newsletter
Firstly some encouraging news of a newly-approved treatment for wet AMD, which could see less frequent hospital visits for those living with the condition. Progress is being made all the time and positive news in treatments and research is due in the coming months.
What do the latest coronavirus restrictions mean for eye care services?
As with previous lockdowns in the UK, if you are currently receiving treatment for macular disease, you should continue to attend your appointments as usual – unless your eye clinic tells you otherwise.
No interruption to medicine supplies for macular patients after Brexit
Patients receiving treatment for macular disease have been reassured that there will be no interruption to medicine supplies due to Brexit, after the transition period ended on 31 December.
New treatment for wet AMD approved for NHS patients
A new reatment for wet age-related macular degeneration (AMD), which could see patients receiving as few as four injections a year, has been approved for use in England and Wales.
Pioneering new eye test may predict wet AMD three years before symptoms appear.
Until now, detection of wet AMD relies on patients themselves seeking expert advice when they notice changes in their vision. But, a new predictive test could detect the condition before symptoms occur.
Read the newsletter in full.
|
|
|
